+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
U.S. Contraceptive Market Forecast to 2033- Product Image
U.S. Contraceptive Market Forecast to 2033- Product Image
New

U.S. Contraceptive Market Forecast to 2033

  • PDF Icon

    Report

  • 80 Pages
  • October 2025
  • Region: United States
  • Grand View Research
  • ID: 4700900
REQUEST CUSTOMIZATION
Description Jump to:
The U.S. contraceptive market size was valued at USD 8.08 billion in 2024 and is expected to reach USD 12.37 billion by 2033, growing at a CAGR of 4.88% from 2025 to 2033. The increase in the use of modern contraceptives and the rise in awareness among adolescents and young people about sexual health and family planning are key factors driving growth. Moreover, government programs have led to an increase in access to contraceptives that help prevent unwanted pregnancies in teenagers.

Continued Innovation in Women’s Contraceptive Health

With the increasing demand, awareness, and preference for reliable alternatives, companies are looking forward to offering safe, effective, and long-term contraceptive options to meet the evolving needs of women worldwide, leading to notable advancements and product launches.

EnilloRing: Expanding Contraceptive Choices

In October 2023, Xiromed LLC introduced EnilloRing (etonogestrel/ethinyl estradiol vaginal ring), a generic alternative to NuvaRing. This product offers long-lasting contraceptive protection and marks an important expansion of Xiromed’s extensive range of women's health medications, which also feature oral contraceptives and transdermal gels.

Rob Spina, CEO of Xiromed, highlighted the impact of this launch:

Manufactured at Laboratorios Leon Pharma SAU in Leon, Spain, EnilloRing underscores Xiromed’s dedication to leveraging cutting-edge technologies as part of Insud Pharma’s commitment to advancing women’s health solutions.

U.S. Contraceptive Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. contraceptive market report based on product.

Product Outlook (Revenue, USD Billion, 2021-2033)

  • Pills
  • Intrauterine Devices (IUD)
  • Condoms
  • Vaginal Ring
  • Subdermal Implants
  • Injectable
  • Others

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Report Deliverables

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.6. Research Assumption
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. Objectives
1.8.1. Objective - 1
1.8.2. Objective - 2
1.8.3. Objective - 3
1.9. List of Secondary Sources
1.10. List of Secondary Sources
Chapter 2. Executive Summary
2.1. U.S. Contraceptive Market
2.1.1. Market Snapshot
2.1.2. Segment Snapshot
2.1.2.1. Product segment outlook
2.1.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Regulatory Framework
3.5. Business Environment Analysis Tools
3.5.1. Industry Analysis - Porter’s Five Forces Analysis
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
Chapter 4. Product Business Analysis
4.1. U.S. Contraceptive Market: Product Movement Analysis
4.2. U.S. Contraceptive Market: Product Segment Dashboard
4.3. Product Movement & Market Share Analysis, 2024 & 2033
4.4. U.S. Contraceptive Market Estimates & Forecast, by Product
4.5. Pills
4.5.1. Pills Market, 2021-2033 (USD Million)
4.6. Intrauterine Devices (IUD)
4.6.1. Intrauterine Devices (IUD) Market, 2021-2033 (USD Million)
4.6.2. Hormonal IUD
4.6.2.1. Hormonal IUD market, 2021-2033 (USD Million)
4.6.3. Nonhormonal IUD
4.6.3.1. Nonhormonal IUD market, 2021-2033 (USD Million)
4.7. Condoms
4.7.1. Condoms Market, 2021-2033 (USD Million)
4.7.2. Male Condoms
4.7.2.1. Male condoms market, 2021-2033 (USD Million)
4.7.3. Female Condoms
4.7.3.1. Female condoms market, 2021-2033 (USD Million)
4.8. Vaginal Ring
4.8.1. Vaginal Ring Market, 2021-2033 (USD Million)
4.9. Subdermal Implants
4.9.1. Subdermal Implants Market, 2021-2033 (USD Million)
4.10. Injectable
4.10.1. Injectable Market, 2021-2033 (USD Million)
4.11. Others
4.11.1. Others Market, 2021-2033 (USD Million)
Chapter 5. Competitive Landscape
5.1. Company Categorization
5.2. Company Market Position Analysis, 2024
5.3. Strategy Mapping
5.3.1. Mergers & Acquisitions
5.3.2. Partnership and Collaborations
5.3.3. New Product Launch
5.3.4. Others
5.4. Company Profiles/Listing
5.4.1. Church & Dwight Co., Inc.
5.4.1.1. Overview
5.4.1.2. Financial performance
5.4.1.3. Product benchmarking
5.4.1.4. Strategic initiatives
5.4.2. Reckitt Benckiser Group Plc
5.4.2.1. Overview
5.4.2.2. Financial performance
5.4.2.3. Product benchmarking
5.4.2.4. Strategic initiatives
5.4.3. Organon Group of Companies
5.4.3.1. Overview
5.4.3.2. Financial performance
5.4.3.3. Product benchmarking
5.4.3.4. Strategic initiatives
5.4.4. Pfizer, Inc.
5.4.4.1. Overview
5.4.4.2. Financial performance
5.4.4.3. Product benchmarking
5.4.4.4. Strategic initiatives
5.4.5. Teva Pharmaceutical Industries Ltd.
5.4.5.1. Overview
5.4.5.2. Financial performance
5.4.5.3. Product benchmarking
5.4.5.4. Strategic initiatives
5.4.6. the Cooper Companies, Inc.
5.4.6.1. Overview
5.4.6.2. Financial performance
5.4.6.3. Product benchmarking
5.4.6.4. Strategic initiatives
5.4.7. Agile Therapeutics
5.4.7.1. Overview
5.4.7.2. Financial performance
5.4.7.3. Product benchmarking
5.4.7.4. Strategic initiatives
5.4.8. Mayer Laboratories, Inc.
5.4.8.1. Overview
5.4.8.2. Financial performance
5.4.8.3. Product benchmarking
5.4.8.4. Strategic initiatives
5.4.9. Mayne Pharma Group Limited.
5.4.9.1. Overview
5.4.9.2. Financial performance
5.4.9.3. Product benchmarking
5.4.9.4. Strategic initiatives
5.4.10. Bayer AG
5.4.10.1. Overview
5.4.10.2. Financial performance
5.4.10.3. Product benchmarking
5.4.10.4. Strategic initiatives
5.4.11. Afaxys, Inc.
5.4.11.1. Overview
5.4.11.2. Financial performance
5.4.11.3. Product benchmarking
5.4.11.4. Strategic initiatives
5.4.12. AbbVie
5.4.12.1. Overview
5.4.12.2. Financial performance
5.4.12.3. Product benchmarking
5.4.12.4. Strategic initiatives
5.4.13. Gedeon Richter
5.4.13.1. Overview
5.4.13.2. Financial performance
5.4.13.3. Product benchmarking
5.4.13.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Contraceptive methods and associated side effects
Table 4 Classification of contraceptives by the U.S. FDA
Table 5 States that have expanded contraceptive coverage guarantee in the Affordable Care Act
Table 6 Types of oral contraceptives, composition, and regimen
Table 7 List of intrauterine devices currently available in the U.S.
Table 8 Types of male condom variants
Table 9 US contraceptive market revenue estimates and forecast, by product, 2021-2033 (USD Million)
List of Figures
Figure 1 U.S. contraceptive market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Market snapshot
Figure 10 Segment snapshot
Figure 11 Competitive landscape
Figure 12 U.S. contraceptive market: Parent market outlook
Figure 13 U.S. contraceptive market dynamics
Figure 14 Market driver relevance analysis (Current & future impact)
Figure 15 Market restraint relevance analysis (Current & future impact)
Figure 16 U.S. contraceptive market: Porter’s five forces analysis
Figure 17 U.S. contraceptive market: PESTLE analysis
Figure 18 U.S. contraceptive market: product segment dashboard
Figure 19 U.S. contraceptive market: product market share analysis, 2024 & 2033
Figure 20 Pills market, 2021-2033 (USD Million)
Figure 21 Intrauterine Devices (IUD) market, 2021-2033 (USD Million)
Figure 22 Hormonal IUD market, 2021-2033 (USD Million)
Figure 23 Nonhormonal IUD market, 2021-2033 (USD Million)
Figure 24 Condoms market, 2021-2033 (USD Million)
Figure 25 Male condoms market, 2021-2033 (USD Million)
Figure 26 Female condoms market, 2021-2033 (USD Million)
Figure 27 Vaginal ring market, 2021-2033 (USD Million)
Figure 28 Subdermal implants market, 2021-2033 (USD Million)
Figure 29 Injectable market, 2021-2033 (USD Million)
Figure 30 Others market, 2021-2033 (USD Million)
Figure 31 Company/competition categorization
Figure 32 Company market position analysis
Figure 33 U.S. contraceptive market: Strategy mapping

Companies Mentioned

The companies profiled in this U.S. Contraceptive market report include:
  • Church & Dwight Co., Inc.
  • Reckitt Benckiser Group Plc
  • Organon Group of Companies
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • The Cooper Companies, Inc.
  • Mayer Laboratories Inc
  • Agile Therapeutics
  • Mayne Pharma Group Limited.
  • Bayer AG
  • Afaxys, Inc.
  • AbbVie
  • Gedeon Richter

Table Information

Report AttributeDetails
No. of Pages80
PublishedOctober 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 8.08 Billion
Forecasted Market Value ( USD ) by 2033 $ 12.37 Billion
Compound Annual Growth Rate4.8%
Regions CoveredUnited States
No. of Companies Mentioned14

Related Topics

Related Reports

Contraceptive Devices Market Report 2025 - Product Image

Contraceptive Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Contraceptive Devices Market Report by Device Type, End User, Distribution Channel, and Region 2025-2033 - Product Image

Contraceptive Devices Market Report by Device Type, End User, Distribution Channel, and Region 2025-2033

  • Report
  • 137 Pages
  • Global
From
North America Contraceptive Market Outlook, 2030 - Product Image

North America Contraceptive Market Outlook, 2030

  • Report
  • 90 Pages
  • North America
From
Contraceptive Market Overview, 2025-30 - Product Image

Contraceptive Market Overview, 2025-30

  • Report
  • 118 Pages
  • Global
From
Contraceptive Drugs and Devices Market Report 2025 - Product Image

Contraceptive Drugs and Devices Market Report 2025

  • Report
  • 250 Pages
  • Global
From

About the Contraception Market

The Contraception market within the context of Personal Care Products is a large and diverse industry. It includes a wide range of products, from condoms and diaphragms to hormonal contraceptives such as the pill and intrauterine devices. Contraception is used to prevent pregnancy and is an important part of sexual health. It is also used to treat certain medical conditions, such as endometriosis. Contraception is widely available in pharmacies, supermarkets, and online. The market for contraception is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Church & Dwight, Bayer, Merck, Pfizer, and Allergan. Other companies include Cipla, Mylan, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.